Comparative evaluation of pharmaceutical products obtained in Mexico: augmenting existing scientific data
- 15 November 2011
- journal article
- Published by Taylor & Francis Ltd in Drug Development and Industrial Pharmacy
- Vol. 38 (7), 808-814
- https://doi.org/10.3109/03639045.2011.628678
Abstract
Context: The accessibility of pharmacies in neighboring countries has facilitated the trend of acquiring medications outside of local borders. However, scientific data assessing the drug content and quality of these medications has not increased in a corresponding fashion. Objective: This study seeks to augment existing scientific data. Materials and methods: Seventeen products that were obtained from pharmacies in Mexico were evaluated for active ingredient content. The active pharmaceutical ingredients (API) assessed included amoxicillin, ampicillin, ciprofloxacin, levothyroxine, sildenafil citrate, sulfamethoxazole, trimethoprim, and warfarin. API content was analysed with high performance liquid chromatography assays and the resultant data interpreted by applying United States Pharmacopeia (USP) acceptability limits. Results: All of the samples analyzed for the two ciprofloxacin products and the two ampicillin products were found to be within the USP limits. Of the four different sulfamethoxazole/trimethoprim products tested, all were within USP limits for sulfamethoxazole, but contained 2–3 individual units which were outside of USP limits for trimethoprim. Several of the remaining products (amoxicillin, levothyroxine, sildenafil citrate, and warfarin) had individual units that fell outside of the USP limits, although only one of the levothyroxine products (1 out of 20 tablets tested) and both sildenafil citrate products (all of the units tested) contained units outside of ±25% label claim.Keywords
This publication has 14 references indexed in Scilit:
- Detection of counterfeit Viagra® by Raman microspectroscopy imaging and multivariate analysisJournal of Pharmaceutical and Biomedical Analysis, 2011
- Development and validation of a ultra-high-performance liquid chromatography-UV method for the detection and quantification of erectile dysfunction drugs and some of their analogues found in counterfeit medicinesJournal of Chromatography A, 2011
- Comparison of Dissolution Properties of 2 Enteric-Coated Formulations Containing Mycophenolate Sodium: Myfortic vs FemulanTransplantation Proceedings, 2010
- Cross-Border Purchase of Medications and Health Care in a Sample of Residents of El Paso, Texas, and Ciudad Juarez, MexicoJournal of the National Medical Association, 2009
- Physiochemical Properties of Generic Formulations of Tacrolimus in MexicoTransplantation Proceedings, 2008
- Counterfeit or substandard antimicrobial drugs: a review of the scientific evidenceJournal of Antimicrobial Chemotherapy, 2007
- Comparison of actual and stated concentrations of pharmaceuticals manufactured in MexicoClinical Therapeutics, 2005
- Comparison of Three Pharmaceutical Products Obtained from Mexico and the United States: A Case StudyDrug Development and Industrial Pharmacy, 2005
- Pilot study of a survey of US residents purchasing medications in Mexico: Demographics, reasons, and types of medications purchasedClinical Therapeutics, 2003
- Stability of essential drugs in SudanThe Lancet, 1991